Why the study?
Age-related ischemic vascular disease is rapidly increasing and poses a huge societal burden, with vascular aging playing a key role in its pathogenesis, morbidity, and mortality.
Understanding and targeting the mechanisms of vascular aging may help prevent and treat age-related ischemic vascular diseases in the growing elderly population.
May support vascular aging targets in ischemic disease; hypothesis-generating and requires randomized trials before clinical adoption.
China is the country with the largest elderly population in the world. Age-related ischemic vascular disease is on a rapidly increasing trend and has brought a huge burden on the whole society. Vascular aging, characterized by vascular dysfunction and aging of the vasculature, plays a key role in the pathogenesis of ischemic vascular disease, morbidity, and mortality of the elderly. This review describes mechanisms and depicts the novel interventional strategies of vascular aging. We propose the significance of vascular aging for early detection, early prevention, and early treatment of age-related ischemic disease and effective improvement of the quality of life in the elderly population. Finally, future directions to develop novel interventions targeting ischemic disease are presented to prevent age-related vascular pathologies.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2020) conducted a review in Vascular aging and age-related ischemic vascular disease. Interventional strategies for vascular aging (e.g., senolytics, metformin, rapamycin, NAD+) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: